These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 1847997)

  • 1. The BZLF1 protein of EBV has a coiled coil dimerisation domain without a heptad leucine repeat but with homology to the C/EBP leucine zipper.
    Kouzarides T; Packham G; Cook A; Farrell PJ
    Oncogene; 1991 Feb; 6(2):195-204. PubMed ID: 1847997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes.
    Bannister AJ; Cook A; Kouzarides T
    Oncogene; 1991 Jul; 6(7):1243-50. PubMed ID: 1907361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-binding specificity of PAR and C/EBP leucine zipper proteins: a single amino acid substitution in the C/EBP DNA-binding domain confers PAR-like specificity to C/EBP.
    Falvey E; Marcacci L; Schibler U
    Biol Chem; 1996 Dec; 377(12):797-809. PubMed ID: 8997490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of dimerization and DNA binding functions in Fos and Jun by domain-swapping: involvement of residues outside the leucine zipper/basic region.
    Cohen DR; Curran T
    Oncogene; 1990 Jun; 5(6):929-39. PubMed ID: 2113670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing fos oncoprotein to a jun-independent DNA binding protein with GCN4 dimerization specificity by swapping "leucine zippers".
    Sellers JW; Struhl K
    Nature; 1989 Sep; 341(6237):74-6. PubMed ID: 2505087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Jun DNA-binding is modulated by mutations between the leucines or by direct interaction of fos with the TGACTCA sequence.
    Hirai S; Yaniv M
    New Biol; 1989 Nov; 1(2):181-91. PubMed ID: 2562220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for coiled-coil dimer formation by an Epstein-Barr virus transactivator that lacks a heptad repeat of leucine residues.
    Flemington E; Speck SH
    Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9459-63. PubMed ID: 2174563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein.
    Petosa C; Morand P; Baudin F; Moulin M; Artero JB; Müller CW
    Mol Cell; 2006 Feb; 21(4):565-72. PubMed ID: 16483937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. fos-jun Conspiracy: implications for the cell.
    Verma IM; Ransone LJ; Visvader J; Sassone-Corsi P; Lamph WW
    Princess Takamatsu Symp; 1989; 20():119-26. PubMed ID: 2518685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encounters with Fos and Jun on the road to AP-1.
    Abate C; Curran T
    Semin Cancer Biol; 1990 Feb; 1(1):19-26. PubMed ID: 2133107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and expression of C/EPB-like genes in the liver of Rana catesbeiana tadpoles during spontaneous and thyroid hormone-induced metamorphosis.
    Chen Y; Hu H; Atkinson BG
    Dev Genet; 1994; 15(4):366-77. PubMed ID: 7923939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addition of positively charged tripeptide to N-terminus of the Fos basic region leucine zipper domain: implications on DNA bending, affinity, and specificity.
    Mahmoudi T; Sarkar B
    Biopolymers; 1999 Sep; 50(3):273-86. PubMed ID: 10397789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZEBRA and a Fos-GCN4 chimeric protein differ in their DNA-binding specificities for sites in the Epstein-Barr virus BZLF1 promoter.
    Taylor N; Flemington E; Kolman JL; Baumann RP; Speck SH; Miller G
    J Virol; 1991 Aug; 65(8):4033-41. PubMed ID: 1649314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. fos and jun interaction: the role of the leucine zipper.
    Ransone LJ; Visvader J; Lamph WW; Sassone-Corsi P; Verma IM
    Int J Cancer Suppl; 1989; 4():10-21. PubMed ID: 2509385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fos, Jun and CREB basic-domain peptides have intrinsic DNA-binding activity enhanced by a novel stabilizing factor.
    Busch SJ; Sassone-Corsi P
    Oncogene; 1990 Oct; 5(10):1549-56. PubMed ID: 2147467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maf and Nrl can bind to AP-1 sites and form heterodimers with Fos and Jun.
    Kerppola TK; Curran T
    Oncogene; 1994 Mar; 9(3):675-84. PubMed ID: 8108109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The GCN4 leucine zipper can functionally substitute for the heat shock transcription factor's trimerization domain.
    Drees BL; Grotkopp EK; Nelson HC
    J Mol Biol; 1997 Oct; 273(1):61-74. PubMed ID: 9367746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrity of FOS B leucine zipper is essential for its interaction with JUN proteins.
    Ryseck RP; Kovary K; Bravo R
    Oncogene; 1990 Jul; 5(7):1091-3. PubMed ID: 2115643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the leucine zipper in the fos-jun interaction.
    Kouzarides T; Ziff E
    Nature; 1988 Dec; 336(6200):646-51. PubMed ID: 2974122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular model for DNA recognition by the family of basic-helix-loop-helix-zipper proteins.
    Vinson CR; Garcia KC
    New Biol; 1992 Apr; 4(4):396-403. PubMed ID: 1622934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.